Suppr超能文献

肠道微生物组在肺部免疫中的贡献。

Contributions of the intestinal microbiome in lung immunity.

机构信息

Department of Pharmaceutical Science and Research, Marshall University School of Pharmacy, Huntington, WV, USA.

Tulane School of Medicine, Center for Translational Research in Infection and Inflammation, New Orleans, LA, USA.

出版信息

Eur J Immunol. 2018 Jan;48(1):39-49. doi: 10.1002/eji.201646721. Epub 2017 Aug 31.

Abstract

The intestine is a critical site of immune cell development that not only controls intestinal immunity but extra-intestinal immunity as well. Recent findings have highlighted important roles for gut microbiota in shaping lung inflammation. Here, we discuss interactions between the microbiota and immune system including T cells, protective effects of microbiota on lung infections, the role of diet in shaping the composition of gut microbiota and susceptibility to asthma, epidemiologic evidence implicating antibiotic use and microbiota in asthma and clinical trials investigating probiotics as potential treatments for atopy and asthma. The systemic effects of gut microbiota are partially attributed to their generating metabolites including short chain fatty acids, which can suppress lung inflammation through the activation of G protein-coupled receptors. Thus, studying the interactions between microbiota and immune cells can lead to the identification of therapeutic targets for chronic lower respiratory diseases.

摘要

肠道是免疫细胞发育的关键部位,不仅控制肠道免疫,还控制肠道外免疫。最近的研究结果强调了肠道微生物群在塑造肺部炎症方面的重要作用。在这里,我们讨论了微生物群与免疫系统(包括 T 细胞)之间的相互作用,微生物群对肺部感染的保护作用,饮食在塑造肠道微生物群组成和易感性方面的作用哮喘、抗生素使用和微生物群在哮喘中的流行病学证据以及临床试验调查益生菌作为治疗特应性和哮喘的潜在疗法。肠道微生物群的全身效应部分归因于它们产生的代谢物,包括短链脂肪酸,通过激活 G 蛋白偶联受体抑制肺部炎症。因此,研究微生物群与免疫细胞之间的相互作用可以为慢性下呼吸道疾病的治疗靶点的确定提供线索。

相似文献

1
Contributions of the intestinal microbiome in lung immunity.
Eur J Immunol. 2018 Jan;48(1):39-49. doi: 10.1002/eji.201646721. Epub 2017 Aug 31.
2
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1.
3
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Front Immunol. 2020 Sep 11;11:2144. doi: 10.3389/fimmu.2020.02144. eCollection 2020.
4
The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
Front Cell Infect Microbiol. 2017 May 5;7:167. doi: 10.3389/fcimb.2017.00167. eCollection 2017.
5
Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells.
Nat Med. 2016 May;22(5):516-23. doi: 10.1038/nm.4068. Epub 2016 Mar 28.
6
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis.
World J Gastroenterol. 2016 Nov 14;22(42):9257-9278. doi: 10.3748/wjg.v22.i42.9257.
7
Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
J Autoimmun. 2017 Sep;83:31-42. doi: 10.1016/j.jaut.2017.03.009. Epub 2017 Mar 23.
9
Intestinal dysbiosis and probiotic applications in autoimmune diseases.
Immunology. 2017 Sep;152(1):1-12. doi: 10.1111/imm.12765. Epub 2017 Jun 29.
10
Microbiota and Food Allergy.
Clin Rev Allergy Immunol. 2019 Aug;57(1):83-97. doi: 10.1007/s12016-018-8723-y.

引用本文的文献

1
Probiotics: A Little Help for Enteral Nutritional Therapy in Critically Ill Adults.
Int J Mol Sci. 2025 Aug 30;26(17):8458. doi: 10.3390/ijms26178458.
2
Respiratory diseases and the gut microbiota: an updated review.
Front Cell Infect Microbiol. 2025 Aug 11;15:1629005. doi: 10.3389/fcimb.2025.1629005. eCollection 2025.
4
Gut microbiota-metabolome crosstalk in allergic diseases: mechanistic insights and translational opportunities.
Front Allergy. 2025 Jul 15;6:1631479. doi: 10.3389/falgy.2025.1631479. eCollection 2025.
5
Microcella aerolata GA224 exhibits preventive potential against Streptococcus pneumoniae infection via the gut-lung axis.
World J Microbiol Biotechnol. 2025 Jul 9;41(7):259. doi: 10.1007/s11274-025-04478-5.
6
Biological mechanisms of pulmonary inflammation and its association with seropositive rheumatoid arthritis.
Front Immunol. 2025 May 23;16:1530753. doi: 10.3389/fimmu.2025.1530753. eCollection 2025.
7
Effects of Neutrophil-Activating Protein of on Th Cytokines and Airway Inflammation in Allergic Asthma.
Adv Biomed Res. 2025 Mar 28;14:28. doi: 10.4103/abr.abr_570_24. eCollection 2025.
10
Altered gut microbiota and metabolite profiles in community-acquired pneumonia: a metagenomic and metabolomic study.
Microbiol Spectr. 2025 Apr;13(4):e0263924. doi: 10.1128/spectrum.02639-24. Epub 2025 Mar 10.

本文引用的文献

1
Nod2: The intestinal gate keeper.
PLoS Pathog. 2017 Mar 2;13(3):e1006177. doi: 10.1371/journal.ppat.1006177. eCollection 2017 Mar.
2
Oral administration of Saccharomyces cerevisiae UFMG A-905 prevents allergic asthma in mice.
Respirology. 2017 Jul;22(5):905-912. doi: 10.1111/resp.12990. Epub 2017 Feb 6.
3
5
Schistosoma mansoni antigens alter activation markers and cytokine profile in lymphocytes of patients with asthma.
Acta Trop. 2017 Feb;166:268-279. doi: 10.1016/j.actatropica.2016.12.002. Epub 2016 Dec 5.
6
Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice.
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8141-E8150. doi: 10.1073/pnas.1617460113. Epub 2016 Nov 23.
7
Homeostasis of the gut barrier and potential biomarkers.
Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G171-G193. doi: 10.1152/ajpgi.00048.2015. Epub 2016 Dec 1.
8
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.
Expert Rev Clin Immunol. 2017 Mar;13(3):223-233. doi: 10.1080/1744666X.2017.1243468. Epub 2016 Oct 14.
9
Immunometabolic circuits in trained immunity.
Semin Immunol. 2016 Oct;28(5):425-430. doi: 10.1016/j.smim.2016.09.002. Epub 2016 Sep 27.
10
Inflammatory bowel disease and airway diseases.
World J Gastroenterol. 2016 Sep 14;22(34):7735-41. doi: 10.3748/wjg.v22.i34.7735.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验